Advanced in Arrhythmias

Benoit Coutu

850 St Denis St, 
Montreal, QC, CA 
Advanced in Arrhythmias
850 St Denis St, 
Montreal, QC, CA 
OverviewLocationsClinical Research

Overview

Benoit Coutu practices in Montreal, Canada. Mr. Coutu is rated as an Advanced expert by MediFind in the treatment of Arrhythmias. His top areas of expertise are Paroxysmal Supraventricular Tachycardia (PSVT), Arrhythmias, Ventricular Fibrillation, Ventricular Tachycardia, and Cardiac Ablation.

His clinical research consists of co-authoring 38 peer reviewed articles and participating in 6 clinical trials. MediFind looks at clinical research from the past 15 years. In particular, he has co-authored 7 articles and participated in 2 clinical trials in the study of Arrhythmias.

Gender
Male

Locations

850 St Denis St, Montreal, QC, Canada

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

6 Clinical Trials

Risk Estimation Following Infarction Noninvasive Evaluation - ICD Efficacy
Risk Estimation Following Infarction Noninvasive Evaluation - ICD Efficacy
Enrollment Status: Completed
Publish Date: May 30, 2025
Intervention Type: Device, Other
Study Phase: Phase 3
Assessment of Primary Prevention Patients Receiving An ICD - Systematic Evaluation of ATP (APPRAISE ATP)
Assessment of Primary Prevention Patients Receiving An ICD - Systematic Evaluation of ATP (APPRAISE ATP)
Enrollment Status: Completed
Publish Date: October 22, 2024
Intervention Type: Device
Study Phase: Not Applicable
Multi-Centre, Randomized, Double-Blind, Placebo-Controlled, Efficacy, and Safety Study of Etripamil Nasal Spray for the Termination of Spontaneous Episodes of Paroxysmal Supraventricular Tachycardia. NODE 301 and RAPID Studies
Multi-Centre, Randomized, Double-Blind, Placebo-Controlled, Efficacy, and Safety Study of Etripamil Nasal Spray for the Termination of Spontaneous Episodes of Paroxysmal Supraventricular Tachycardia. NODE 301 and RAPID Studies
Enrollment Status: Terminated
Publish Date: July 12, 2024
Intervention Type: Drug
Study Drug: Etripamil
Study Phase: Phase 3
Resynchronization/Defibrillation for Ambulatory Heart Failure Trial in Patients With Permanent Atrial Fibrillation
Resynchronization/Defibrillation for Ambulatory Heart Failure Trial in Patients With Permanent Atrial Fibrillation
Enrollment Status: Active_not_recruiting
Publish Date: May 10, 2024
Intervention Type: Device
Study Phase: Not Applicable
Multi-Center, Placebo-Controlled, Dose-Ranging Phase 2 Electrophysiological Study of Intranasal Administration of MSP-2017 for the Conversion of Induced Paroxysmal Supraventricular Tachycardia (PSVT) to Sinus Rhythm
Multi-Center, Placebo-Controlled, Dose-Ranging Phase 2 Electrophysiological Study of Intranasal Administration of MSP-2017 for the Conversion of Induced Paroxysmal Supraventricular Tachycardia (PSVT) to Sinus Rhythm
Enrollment Status: Completed
Publish Date: December 30, 2020
Intervention Type: Drug
Study Phase: Phase 2
A Randomized Controlled Trial to Investigate Whether a Strategy of Continued Versus Interrupted Novel Oral Anti-coagulant at the Time of Device Surgery, in Patients With Moderate to High Risk of Arterial Thrombo-embolic Events, Leads to a Reduction in the Incidence of Clinically Significant Hematoma
A Randomized Controlled Trial to Investigate Whether a Strategy of Continued Versus Interrupted Novel Oral Anti-coagulant at the Time of Device Surgery, in Patients With Moderate to High Risk of Arterial Thrombo-embolic Events, Leads to a Reduction in the Incidence of Clinically Significant Hematoma
Enrollment Status: Completed
Publish Date: October 07, 2019
Intervention Type: Drug
Study Phase: Phase 3
View 5 Less Clinical Trials

38 Total Publications

Atrial fibrillation progression in patients with device-detected subclinical atrial fibrillation: Insights from the ARTESiA trial.
Atrial fibrillation progression in patients with device-detected subclinical atrial fibrillation: Insights from the ARTESiA trial.
Journal: Heart rhythm
Published: May 29, 2025

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Mr. Coutu's expertise for a condition
ConditionClose
    View All 7 Experienced Conditions
    Want to save this expert for later?
    Sign Up
    Not sure about your diagnosis?
    Check Your Symptoms
     
     
     
     
    Learn about our expert tiers
    Learn More
    Are you the provider on this profile?
    Claim Profile